Cargando…
Neoadjuvant trials in early breast cancer: pathological response at surgery and correlation to longer term outcomes – what does it all mean?
BACKGROUND: Neoadjuvant breast cancer trials are important for speeding up the introduction of new treatments for patients with early breast cancer and for the highly productive translational research which they facilitate. Meta-analysis of trial data shows clear correlation between pathological res...
Autores principales: | Earl, Helena, Provenzano, Elena, Abraham, Jean, Dunn, Janet, Vallier, Anne-Laure, Gounaris, Ioannis, Hiller, Louise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578850/ https://www.ncbi.nlm.nih.gov/pubmed/26391216 http://dx.doi.org/10.1186/s12916-015-0472-7 |
Ejemplares similares
-
Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer
por: Ali, H. Raza, et al.
Publicado: (2016) -
The challenges of using radiological ‘tumour response' as an outcome: lessons learned from neo-tango and artemis, two neo-adjuvant chemotherapy breast cancer trials
por: Hiller, Louise, et al.
Publicado: (2013) -
“Protein” no longer means what it used to
por: Parisi, Gustavo, et al.
Publicado: (2021) -
What the Lactate Shuttle Means for Sports Nutrition
por: Brooks, George A.
Publicado: (2023) -
Trastuzumab-associated cardiac events in the Persephone trial
por: Earl, Helena M, et al.
Publicado: (2016)